Intro

This chapter explores recent treatment updates for Leber's hereditary optic neuropathy (LHON), including the genetic mutations that contribute to the disorder. It specifically highlights the potential of idebenone, an antioxidant medication, to improve outcomes for patients suffering from vision loss due to this condition.